Clinical Trial

Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases

Completed
View on ClinicalTrials.gov →
Summary
This is a single-center, open lable, single-arm phase II clinical study to evaluate the efficacy and safety of fractionated stereotactic radiotherapy (FSRT) in patients with 1-4 brain metastases with ≤2cm in diameter.
Trial Details
NCT Number NCT07405047
Lead Sponsor Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions Brain Metastases, Adult
Enrollment 33 participants
Start Date 2022-09-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-12